Aspirin following non-arteritic ischaemic optic neuropathy a systematic review and meta-analysis
From DARE: the review concluded that there was a benefit of aspirin in prevention of second eye NAION. However, the evidence was weak (acknowledged by the authors) and concerns about the quality, quantity and heterogeneity of the evidence used to produce the pooled estimate made its reliability questionable. The authors' conclusion should be treated with caution.